Jatinder Bisla

2023
Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial
Marsden, J., Kelleher, M., Gilvarry, E., Mitcheson, L., Bisla, J., Cape, A., Cowden, F., Day, E., Dewhurst, J., Evans, R., Hardy, W., Hearn, A., Kelly, J., Lowry, N., McCusker, M., Murphy, C., Murray, R., Myton, T., Quarshie, S. & Vanderwaal, R. & 3 others, Wareham, A., Hughes, D. & Hoare, Z., Dec 2023, In: EClinicalMedicine. 66, 23 p., 102311.
Research output: Contribution to journal › Article › peer-review

Open Access
9 Citations (Scopus)
2017
Low-dose intravenous immunoglobulin treatment for long-standing complex regional pain syndrome: a randomized trial
Goebel, A., Bisla, J., Carganillo, R., Frank, B., Gupta, R., Kelly, J., McCabe, C., Murphy, C., Padfield, N., Phillips, C., Sanders, M., Serpell, M., Shenker, N., Shoukrey, K., Wyatt, L. & Ambler, G., 3 Oct 2017, In: Annals of Internal Medicine. 167, 7, p. 476-483 8 p.
Research output: Contribution to journal › Article › peer-review
41 Citations (Scopus)

Research output